The formulations facility of Strides Pharma Science Ltd in Bangalore recently underwent pre-approval product inspection by the USFDA. The inspection ended on August 25, 2018 and the company has been issued a Form 483 with 3 observations. The Company believes that the observations are not material in nature and we have already responded to the USFDA.
The Company has recently (post completion of the inspection) received a product approval for Potassium Chloride Extended Release Tablets from this facility.
Shares of Strides Shasun Ltd was last trading in BSE at Rs.499.1 as compared to the previous close of Rs. 508.7. The total number of shares traded during the day was 193405 in over 3101 trades.
The stock hit an intraday high of Rs. 516.2 and intraday low of 496.75. The net turnover during the day was Rs. 97770311.